Organigram Global (OGI) Accounts Payables (2018 - 2026)
Organigram Global (OGI) posted quarterly Accounts Payables of $53.3 million for Q1 2026, up 4.64% on a QoQ basis from $51.0 million in Q4 2025.
Organigram Global (OGI) Accounts Payables (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Accounts Payables for 9 consecutive years, with $53.3 million the latest figure, recorded in Q1 2026.
- Quarterly Accounts Payables changed N/A year-over-year to $53.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.3 million (changed N/A YoY) and the FY2025 annual result came in at $51.0 million, changed N/A from the prior year.
- Accounts Payables climbed to $53.3 million in Q1 2026 per OGI's latest filing, from $51.0 million in the prior quarter.
- Over the last five years, Accounts Payables for OGI reached as high as $64.8 million in Q3 2025 and fell as low as $14.9 million in Q3 2023.
- A 5-year average of $41.7 million and a median of $42.7 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables jumped 131.34% — and 2025, when it soared 87.84%.
- Year by year, Accounts Payables stood at $31.7 million in 2022, then sank by 52.97% to $14.9 million in 2023, then jumped by 131.34% to $34.5 million in 2024, then soared by 47.63% to $51.0 million in 2025, then gained by 4.64% to $53.3 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $53.3 million, $51.0 million, and $64.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | 53.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.33 Mn |
| Dec 31, 2025 | 50.97 Mn |
| Sep 30, 2025 | 64.85 Mn |
| Sep 30, 2024 | 34.52 Mn |
| Sep 30, 2023 | 14.92 Mn |
| Aug 31, 2022 | 31.73 Mn |
| Nov 30, 2021 | 27.00 Mn |
| Aug 31, 2021 | 15.25 Mn |
| May 31, 2021 | 19.28 Mn |
| Feb 28, 2021 | 13.81 Mn |
| Nov 30, 2020 | 17.11 Mn |
| Aug 31, 2020 | 13.01 Mn |
| May 31, 2020 | 17.88 Mn |
| Feb 29, 2020 | 26.67 Mn |
| Aug 31, 2019 | 30.52 Mn |
| May 31, 2019 | 23.40 Mn |
| Aug 31, 2018 | 8.22 Mn |